Skip to Main Content

Author Details

Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
2001
227
32
PMIDPaper TitleJournal TitlePublished Year
37118959Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter Study.World J Mens Health2024
38000052Impact of urinary diversion type on urethral recurrence following radical cystectomy for bladder cancer: propensity score matched and weighted analyses of retrospective cohort.Int J Surg2024
36254631Repression of SLC22A3 by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer.FEBS J2023
37745907Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer.Prostate Int2023
37509551Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.Biomedicines2023
37080605TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort.Cancer Res Treat2023
37409092Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy.Prostate Int2023
37076275The utility of two-dimensional shear wave elastography for predicting prostate cancer: a preliminary study.Ultrasonography2023
36835404Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.Int J Mol Sci2023
36929129New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles' operation.Insights Imaging2023
36167777Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy.Eur Urol Focus2023
36228654Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder.Cancer Res Treat2023
34793662Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy.Cancer Res Treat2022
35740362Clinical Implication of Preoperative Renal Function on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.Biomedicines2022
35510096Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1-2 on multiparametric magnetic resonance imaging.Prostate Int2022
35675311Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.PLoS One2022
35437959Catheter-associated urinary tract infections in patients who have undergone radical cystectomy for bladder cancer: A prospective randomized clinical study of two silicone catheters (clinical benefit of antibiotic silicone material).Investig Clin Urol2022
35574412A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.Front Oncol2022
35626196Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.Diagnostics (Basel)2022
35626101Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study.Cancers (Basel)2022
35625960Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma.Cancers (Basel)2022
36291981A Comparison of Functional and Oncologic Outcomes between Partial Nephrectomy and Radiofrequency Ablation in Patients with Chronic Kidney Disease after Propensity Score Matching.Diagnostics (Basel)2022
36009553Subsequent Systemic Therapy following Platinum and Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.Biomedicines2022
36077710Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions.Cancers (Basel)2022
33857365Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma.Cancer Res Treat2022
34983123Gender-related outcomes in robot-assisted radical cystectomy: A multi-institutional study.Investig Clin Urol2022
35244990Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.Investig Clin Urol2022
34907105Genetic Counseling and Long-Term Surveillance Using a Multidisciplinary Approach in von Hippel-Lindau Disease.Ann Lab Med2022
35141158TRUS-Guided Target Biopsy for a PI-RADS 3-5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis.Front Oncol2022
35137466Predicting factor analysis of postoperative complications after robot-assisted radical cystectomy: Multicenter KORARC database study.Int J Urol2022
32682331Oncological outcome according to attainment of pentafecta after robot-assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database.BJU Int2021
33817907Association between cancer stigma and job loss among cancer survivors.Psychooncology2021
33692449Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma.Sci Rep2021
33584544Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.Front Endocrinol (Lausanne)2021
33837237Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma.Sci Rep2021
33660451Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance.Investig Clin Urol2021
33916347Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities.Biology (Basel)2021
34944964Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer.Cancers (Basel)2021
34753990ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT).Sci Rep2021
34753938Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels.Sci Rep2021
34634058A retrospective multicenter comparison of conditional cancer-specific survival between laparoscopic and open radical nephroureterectomy in locally advanced upper tract urothelial carcinoma.PLoS One2021
34692504Conditional Intravesical Recurrence-Free Survival Rate After Radical Nephroureterectomy With Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.Front Oncol2021
34768437Preoperative versus Postoperative Compensation of the Contralateral Normal Kidney in Patients Treated with Radical Nephrectomy for Renal Cell Carcinoma.J Clin Med2021
34768322The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy.J Clin Med2021
33939714Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.PLoS One2021
33957718Comparison of Efficacy of Different Surgical Techniques for Benign Prostatic Obstruction.Int Neurourol J2021
34262353Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?Cancer Manag Res2021
34235097Comparison of Risk Factors for the Development of Proteinuria After Radical Nephrectomy for Renal Cell Carcinoma.Res Rep Urol2021
34136407The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up.Front Oncol2021
33421984Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.Cancer Res Treat2021
  • 1 - 50 of 227

Recommended Authors

Giovanni Motterle
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 1
Jiayu Liang
institute of urology
Career Start Year 2016
Number of shared co-authors 0
Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey
Career Start Year 2016
Number of shared co-authors 1
Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year 2015
Number of shared co-authors 0
Riccardo Campi
Careggi University Hospital
Career Start Year 2014
Number of shared co-authors 1
Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 2
David C Johnson
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Shinji Ohtake
Institute of Urologic Oncology, University of California los angeles
Career Start Year 2010
Number of shared co-authors 0
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 1
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Joseph Brito
Yale School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 2
Paul L Crispen
University of Florida
Career Start Year 2005
Number of shared co-authors 0
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 0
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 1
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 2
Lin Qi
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 2
Karim Chamie
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 1
Hak J Lee
university of california san diego School of Medicine
Career Start Year 1998
Number of shared co-authors 2
Surena F Matin
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 3
Omer Acar
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 0
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 1
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 1
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Career Start Year 1992
Number of shared co-authors 10
Damien Bolton
University of Melbourne
Career Start Year 1988
Number of shared co-authors 0
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 2
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 4

Collaborators

Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 154
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 149
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 14
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers 13
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 7
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 7
Ji Youl Lee
Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Co-authored papers 7
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 5
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 4
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers 4
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 4
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers 3
Yong Hyun Park
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Co-authored papers 3
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers 2
Ithaar H Derweesh
university of california san diego School of Medicine
Co-authored papers 2
Sang Shin
Feinberg School of Medicine, Northwestern University
Co-authored papers 2
Kyoung-Mee Kim
Seoul National University College of Medicine
Co-authored papers 2
Phillip M Pierorazio
Co-authored papers 2
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers 2
Jason K Sa
Korea University, College of Medicine
Co-authored papers 2
Young Mog Shim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Hae-Ock Lee
College of Medicine, The Catholic University of Korea
Co-authored papers 2
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers 1
Paul M Ness
Johns Hopkins University
Co-authored papers 1
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers 1
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 1
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 1
Kyung Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 1
Release 1.2